ArticleOphthalmology and therapy2026
Scheimpflug Photography-Based Evaluation of Structural Iris Changes Across Keratoconus Stages in Comparison with Healthy Eyes.
Article in Ophthalmology and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionKeratoconus (KC) is a progressive corneal disorder caused by impaired biomechanical integrity, leading to geometric deformation. Although corneal changes are well characterized, iris structural alterations across KC stages remain poorly studied. Accordingly, this study aims to compare quantitative iris characteristics among healthy controls and patients with different stages of KC.
methodsThis retrospective cross-sectional study included 547 eyes: 497 from 264 keratoconus subjects classified according to the Topographic Keratoconus Classification (TKC) system as subclinical (n = 102), early stage (n = 219, TKC 1-2), and late-stage (n = 176, TKC 3-4), and single eyes from 50 healthy emmetropic controls. Anterior segment imaging was performed using Pentacam Scheimpflug tomography. Iris segmentation was achieved using a semi-automated Python-based pipeline incorporating the Segment Anything Model, followed by extraction of the anterior iris boundary. The iris was subdivided into basal, mid-iris, and pupil-edge regions. Region-specific geometric parameters, including curvature, arc length, and area under the curve (AUC), were computed using spline-based fitting and numerical integration. Group comparisons were conducted using one-way analysis of variance with false discovery rate correction, followed by age-adjusted analysis of covariance.
resultsMean basal and mid-iris curvature showed significant overall differences across TKC stages, with a progressive reduction from healthy controls to late-stage KC (p = 0.01 and p < 0.001, respectively). In contrast, pupil-edge curvature showed an opposite trend, with the highest values in late-stage KC (p = 0.02). Iris arc length did not differ significantly between groups, whereas AUC exhibited a region-specific difference limited to the pupil-edge iris (p = 0.02). These findings remained statistically significant after age adjustment.
conclusionsIncreased pupil-edge curvature in KC represents a geometric alteration that may be clinically relevant in eyes undergoing intraocular surgery, particularly in relation to anterior chamber dynamics and potential susceptibility to postoperative pupillary block. Conversely, mid-iris straightening may reflect structural variation within the iris in late-stage disease. Together, these findings suggest that corneal geometric changes in KC may be associated with subtle alterations in anterior chamber mechanical environment, potentially contributing to secondary changes in iris configuration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.